Tuan Vu, MD, explains the results of the NIMBLE trial, whose results will be presented at the American Academy of Neurology ...
SPIRIT-HF missed its primary composite endpoint at 2 years, with higher observed event rates on spironolactone versus placebo ...
An estimated 658,704 children above 200% FPL experienced food insecurity, with 47.3% living at 201%–250% FPL, suggesting ...
Objective: To examine the association between a health insurance plan offering a grocery assistance benefit to members with ...
Chemotherapy sequencing in the ARPI era and the role of radiopharmaceuticals versus docetaxel remain unsettled, while ...
The landscape of psoriasis management has been transformed over the past two decades, and real-world data from meetings like ...
The management of cutaneous squamous cell carcinoma (CSCC) is undergoing a notable shift, with systemic immunotherapy playing ...
Radium-223 retains a role in osteoblastic bone-only disease, while PSMA PET has become indispensable across staging, ...
Real-world data from the OPERA cohort are challenging long-standing assumptions about when long-acting cabotegravir plus ...
Yet nutrition does matter—and national dietary guidelines help provide a framework for counseling. The Dietary Guidelines for ...
Immunotherapy—particularly PD-1 inhibition with cemiplimab—is reshaping CSCC care by expanding into neoadjuvant and adjuvant ...
Outcome-weighted metrics (mortality, 5-year survival, MIR) better capture unmet need than incidence alone when assessing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results